CN103735494B - 治疗蚊虫叮咬的外用止痒乳膏及其制备方法 - Google Patents
治疗蚊虫叮咬的外用止痒乳膏及其制备方法 Download PDFInfo
- Publication number
- CN103735494B CN103735494B CN201410015289.4A CN201410015289A CN103735494B CN 103735494 B CN103735494 B CN 103735494B CN 201410015289 A CN201410015289 A CN 201410015289A CN 103735494 B CN103735494 B CN 103735494B
- Authority
- CN
- China
- Prior art keywords
- stirring
- oil phase
- minutes
- clean area
- external
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001139 anti-pruritic effect Effects 0.000 title claims abstract description 36
- 239000003908 antipruritic agent Substances 0.000 title claims abstract description 35
- 206010003399 Arthropod bite Diseases 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title abstract description 38
- 239000002674 ointment Substances 0.000 title abstract description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 67
- 208000003251 Pruritus Diseases 0.000 claims abstract description 48
- 230000001954 sterilising effect Effects 0.000 claims abstract description 25
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000001914 filtration Methods 0.000 claims abstract description 14
- 239000008213 purified water Substances 0.000 claims abstract description 12
- 239000012528 membrane Substances 0.000 claims abstract description 11
- 239000006071 cream Substances 0.000 claims description 71
- 238000003756 stirring Methods 0.000 claims description 56
- 230000007803 itching Effects 0.000 claims description 41
- 238000003860 storage Methods 0.000 claims description 34
- 238000010008 shearing Methods 0.000 claims description 33
- 239000000463 material Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000007788 liquid Substances 0.000 claims description 12
- 238000004806 packaging method and process Methods 0.000 claims description 10
- 238000005086 pumping Methods 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 230000002829 reductive effect Effects 0.000 claims description 7
- 238000009924 canning Methods 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 abstract description 23
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract description 17
- 235000011114 ammonium hydroxide Nutrition 0.000 abstract description 17
- 239000000546 pharmaceutical excipient Substances 0.000 abstract description 12
- 239000004480 active ingredient Substances 0.000 abstract description 11
- 238000001816 cooling Methods 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 229940057995 liquid paraffin Drugs 0.000 abstract description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 abstract description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 abstract description 3
- 229920000053 polysorbate 80 Polymers 0.000 abstract description 3
- 229940068968 polysorbate 80 Drugs 0.000 abstract description 3
- 230000007012 clinical effect Effects 0.000 abstract description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 abstract 1
- 239000000908 ammonium hydroxide Substances 0.000 abstract 1
- 230000000249 desinfective effect Effects 0.000 abstract 1
- 229940008099 dimethicone Drugs 0.000 abstract 1
- 239000004205 dimethyl polysiloxane Substances 0.000 abstract 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 abstract 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 62
- 239000003814 drug Substances 0.000 description 34
- 229910021529 ammonia Inorganic materials 0.000 description 30
- 210000003491 skin Anatomy 0.000 description 27
- 206010015150 Erythema Diseases 0.000 description 23
- 238000012360 testing method Methods 0.000 description 23
- 206010030113 Oedema Diseases 0.000 description 22
- 231100000321 erythema Toxicity 0.000 description 22
- 229940079593 drug Drugs 0.000 description 18
- 239000000047 product Substances 0.000 description 17
- 241000255925 Diptera Species 0.000 description 12
- 206010070834 Sensitisation Diseases 0.000 description 11
- 230000008313 sensitization Effects 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 230000000699 topical effect Effects 0.000 description 9
- 241000700199 Cavia porcellus Species 0.000 description 8
- 239000004471 Glycine Substances 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 8
- 230000000694 effects Effects 0.000 description 8
- 241000283973 Oryctolagus cuniculus Species 0.000 description 7
- 241000700198 Cavia Species 0.000 description 6
- 206010020751 Hypersensitivity Diseases 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 238000013112 stability test Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 239000006068 taste-masking agent Substances 0.000 description 5
- 206010002198 Anaphylactic reaction Diseases 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 208000003455 anaphylaxis Diseases 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 230000007794 irritation Effects 0.000 description 4
- 230000007774 longterm Effects 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- 238000004659 sterilization and disinfection Methods 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 241000238631 Hexapoda Species 0.000 description 3
- 208000030961 allergic reaction Diseases 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000002951 depilatory effect Effects 0.000 description 3
- 230000005284 excitation Effects 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 230000037311 normal skin Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000000638 stimulation Effects 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 206010033733 Papule Diseases 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 208000026935 allergic disease Diseases 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000035617 depilation Effects 0.000 description 2
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 230000008595 infiltration Effects 0.000 description 2
- 238000001764 infiltration Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 229910000069 nitrogen hydride Inorganic materials 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920002545 silicone oil Polymers 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000004448 titration Methods 0.000 description 2
- 241000256111 Aedes <genus> Species 0.000 description 1
- 206010001526 Air embolism Diseases 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 241000256186 Anopheles <genus> Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000256054 Culex <genus> Species 0.000 description 1
- 208000001490 Dengue Diseases 0.000 description 1
- 206010012310 Dengue fever Diseases 0.000 description 1
- VYZAHLCBVHPDDF-UHFFFAOYSA-N Dinitrochlorobenzene Chemical compound [O-][N+](=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 VYZAHLCBVHPDDF-UHFFFAOYSA-N 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- 201000006353 Filariasis Diseases 0.000 description 1
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 241000500891 Insecta Species 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 231100000493 OECD 406 (Buehler) Skin Sensitisation Toxicity 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 206010070835 Skin sensitisation Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 210000003323 beak Anatomy 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 208000025729 dengue disease Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000010339 dilation Effects 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 239000012738 dissolution medium Substances 0.000 description 1
- 238000007922 dissolution test Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002497 edematous effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000008098 formaldehyde solution Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000036512 infertility Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- CEQFOVLGLXCDCX-WUKNDPDISA-N methyl red Chemical compound C1=CC(N(C)C)=CC=C1\N=N\C1=CC=CC=C1C(O)=O CEQFOVLGLXCDCX-WUKNDPDISA-N 0.000 description 1
- 229960002744 mometasone furoate Drugs 0.000 description 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- -1 polyethylene Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 238000001223 reverse osmosis Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 231100000370 skin sensitisation Toxicity 0.000 description 1
- 239000000779 smoke Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 208000002271 trichotillomania Diseases 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
处方组分 | 1 | 2 | 3 | 4 | 5 | 6 |
氨水(26.5%) | 13.2 | 13.2 | 13.2 | 13.2 | 13.2 | 13.2 |
聚山梨酯80 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 | 4.7 |
甘氨酸 | 0 | 1.7 | 2.7 | 3.7 | 4.7 | 5.7 |
二甲基硅油 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 |
液体石蜡 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 | 1.9 |
纯化水 | 78.3 | 76.6 | 75.6 | 74.6 | 73.6 | 72.6 |
原辅料名称 | 生产企业 | 执行标准 |
氨水 | 南京化学试剂有限公司 | 中国药典2010版二部 |
聚山梨酯80 | 南京威尔化工有限公司 | 中国药典2010版二部 |
甘氨酸 | 晋州冀荣氨基酸有限公司 | 中国药典2010版二部 |
二甲基硅油 | 自贡鸿鹤制药有限责任公司 | 中国药典2010版二部 |
液体石蜡 | 中国石化集团杭州炼油厂 | 中国药典2010版二部 |
纯化水 | 山东司邦得制药有限公司 | 中国药典2010版二部 |
刺激反应 | 分值 |
红斑 | |
无红斑 | 0 |
轻度红斑(勉强可见) | 1 |
中度红斑(明显可见) | 2 |
重度红斑 | 3 |
***红斑到轻度焦痂形成 | 4 |
水肿 | |
无水肿 | 0 |
轻度水肿(勉强可见) | 1 |
中度水肿(明显***) | 2 |
重度水肿(皮肤***1mm,轮廓清楚) | 3 |
严重水肿(皮肤***1mm以上并有扩大) | 4 |
高总积分 | 8 |
分值 | 评价 |
0~0.49 | 无刺激性 |
0.5~2.99 | 轻度刺激性 |
3.0~5.99 | 中度刺激性 |
6.0~8.0 | 强刺激性 |
皮肤反应强度 | 分值 |
红斑 | |
无红斑 | 0 |
轻微可见红斑 | 1 |
中度红斑 | 2 |
严重红斑 | 3 |
肿性红斑 | 4 |
水肿 | |
无水肿 | 0 |
轻度水肿 | 1 |
中度水肿 | 2 |
严重水肿 | 3 |
最大总积分 | 7 |
过敏反应发生率(%) | 分级 | 过敏反应强度 |
0~8 | Ⅰ | 弱敏 |
9~18 | Ⅱ | 轻度致敏 |
29~64 | Ⅲ | 中度致敏 |
65~80 | Ⅳ | 强致敏 |
81~100 | Ⅴ | 极强致敏 |
组别 | 初次致敏 | 末次致敏 | 激发 |
赋形剂对照组 | 341.3±5.0 | 375.2±5.0 | 408.8±5.4 |
阳性对照组 | 343.9±12.0 | 377.5±11.9 | 410.9±12.0 |
供试品组 | 345.4±18.6 | 379.0±18.4 | 412.3±18.5 |
组别 | 例数 | 治愈 | 好转 | 无效 | 总有效率% |
治疗组 | 50 | 30 | 19 | 1 | 98 |
对照组 | 50 | 28 | 21 | 1 | 98 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410015289.4A CN103735494B (zh) | 2014-01-14 | 2014-01-14 | 治疗蚊虫叮咬的外用止痒乳膏及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410015289.4A CN103735494B (zh) | 2014-01-14 | 2014-01-14 | 治疗蚊虫叮咬的外用止痒乳膏及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103735494A CN103735494A (zh) | 2014-04-23 |
CN103735494B true CN103735494B (zh) | 2015-07-01 |
Family
ID=50492615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410015289.4A Active CN103735494B (zh) | 2014-01-14 | 2014-01-14 | 治疗蚊虫叮咬的外用止痒乳膏及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103735494B (zh) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109481674A (zh) * | 2018-11-14 | 2019-03-19 | 大连亚维药业有限公司 | 一种生物无菌乳膏药物的生产方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1661545A1 (fr) * | 2004-10-15 | 2006-05-31 | L'oreal | Crème à base d'acide gras sous forme d'émulsion H/E |
CN101422427A (zh) * | 2005-09-28 | 2009-05-06 | 江苏正大天晴药业股份有限公司 | 异甘草酸镁乳膏制剂及其制备方法和应用 |
CN103006689A (zh) * | 2012-12-25 | 2013-04-03 | 长春普莱医药生物技术有限公司 | 止痒组合物及其在制备止痒剂中的应用 |
-
2014
- 2014-01-14 CN CN201410015289.4A patent/CN103735494B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1661545A1 (fr) * | 2004-10-15 | 2006-05-31 | L'oreal | Crème à base d'acide gras sous forme d'émulsion H/E |
CN101422427A (zh) * | 2005-09-28 | 2009-05-06 | 江苏正大天晴药业股份有限公司 | 异甘草酸镁乳膏制剂及其制备方法和应用 |
CN103006689A (zh) * | 2012-12-25 | 2013-04-03 | 长春普莱医药生物技术有限公司 | 止痒组合物及其在制备止痒剂中的应用 |
Non-Patent Citations (1)
Title |
---|
皮炎乳膏治疗毒隐翅虫炎86例临床观察;吴季俭 等;《四川中医》;19831231(第1期);53-54页 * |
Also Published As
Publication number | Publication date |
---|---|
CN103735494A (zh) | 2014-04-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104224923A (zh) | 治疗妇科***疾病的茶树精油抗菌凝胶 | |
US10231990B2 (en) | Preservative-free composition for topical use including hyaluronic acid | |
CN105434337B (zh) | 盐酸***亚微乳凝胶及其制备方法和用途 | |
CN101843637B (zh) | 一种防治脚气的外用喷剂及制备方法 | |
CN106138190B (zh) | 一种外用凝胶制剂、制备方法及其用途 | |
US10478463B2 (en) | External-use medicament for cleaning and care of the ovaries, vagina, and vulva | |
CN102178939B (zh) | 治疗皮肤溃疡的盐酸溶菌酶外用无菌乳膏及其制备方法 | |
CN113274342A (zh) | 一种秋水仙碱外用组合物 | |
CN110974861B (zh) | 一种艾纳香油脂质体 | |
CN113509457A (zh) | 山椒素在制备治疗湿疹的药物中的用途 | |
CN103735494B (zh) | 治疗蚊虫叮咬的外用止痒乳膏及其制备方法 | |
CN106237029B (zh) | 一种芦荟抗菌凝胶及其制备方法 | |
CN104274391B (zh) | 一种含利福昔明的药物制剂 | |
CN101982198A (zh) | 一种治疗奶牛子宫炎的灌注油剂及其制备方法 | |
CN103285213B (zh) | 一种广谱皮肤外用中药制剂及其制备方法 | |
CN104274494B (zh) | 一种美洲大蠊外用制剂及其制备方法 | |
RU2535023C1 (ru) | Средство для лечения воспаления вымени у коров | |
CN112006987B (zh) | 一种治疗鼻炎的冷敷凝胶及其之制备方法 | |
CN109453146A (zh) | 抗病原微生物的组合物及其制备方法和应用 | |
CN104758310B (zh) | 复方蒙脱石蔗糖软膏及其制备方法和应用 | |
CN116270828B (zh) | 一种用于创面愈合的中药组合物及其制备方法 | |
CN113230293B (zh) | 一种消风败毒的中药组合物及其制备方法 | |
CN107050393A (zh) | 舒痹散结膏及其制备方法与应用 | |
CN109771394B (zh) | 一种山藿香消炎涂膜剂及其制备方法 | |
CN105193934B (zh) | 一种用于治疗家畜子***的复方精油及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190416 Address after: 265209 Food Industrial Park, Laiyang City, Shandong Province Patentee after: LAIYANG SBOND PHARMACEUTICAL CO.,LTD. Address before: 250216 Longhu Road East, Longshan Office, Zhangqiu City, Jinan City, Shandong Province Patentee before: SHANDONG SIBANGDE PHARMACEUTICAL Co.,Ltd. |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: External antipruritic cream for treating mosquito bites and its preparation method Effective date of registration: 20230704 Granted publication date: 20150701 Pledgee: Postal Savings Bank of China Limited Laiyang sub branch Pledgor: LAIYANG SBOND PHARMACEUTICAL CO.,LTD. Registration number: Y2023980047332 |